News|Articles|March 6, 2025
How Regulatory Oversight Protects CBD Consumers
Author(s)Benuvia
Many consumers trust that a Certificate of Analysis (COA) guarantees product safety, but without strict regulatory oversight, that’s not always the case. This white paper provides insights into what consumers and businesses should look for in a truly safe, high-quality, and consistent product.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Leveraging AI/ML to Reduce Risk in Drug Development: Part One
3
New Targets for Clinical Trials in the European Union
4
Nuclear Waste to Medicine: The UK’s Lead-212 Strategy for Cancer Care
5
